Herlev Hospital: Pancreatic Neoplasms trials

The registry lists 10 Pancreatic Neoplasms studies with Herlev Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 7No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Molecularly Tailored Therapy in Advanced Pancreatic CancerNot yet recruitingNCT07802418Phase 2
• The Role of Microbiota in Pancreatic Cancer and Precursor LesionsRecruitingNCT07250100
• Pharmacotyping of Pancreatic Patient-derived OrganoidsRecruitingNCT05196334
• Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.TerminatedNCT05116917Phase 2
• Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic CancerTerminatedNCT04258150Phase 2
• Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.CompletedNCT04247165Phase 1/2
• Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer PatientsCompletedNCT02866383Phase 2
• Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic CancerTerminatedNCT02767752Phase 2
• Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer PatientsCompletedNCT02767557Phase 2
• Needle-based Confocal Endomicroscopy Examination of Pancreatic MasseCompletedNCT01734967Not applicable